154 related articles for article (PubMed ID: 35691155)
1. Spirulina phycocyanin extract and its active components suppress epithelial-mesenchymal transition process in endometrial cancer via targeting TGF-beta1/SMAD4 signaling pathway.
Chen HY; Chiang YF; Huang CY; Shieh TM; Kao C; Chang FK; Huang TC; Ali M; Chang HY; Hong YH; Hsia SM
Biomed Pharmacother; 2022 Aug; 152():113219. PubMed ID: 35691155
[TBL] [Abstract][Full Text] [Related]
2. C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells.
Ji H; Liu G; Han J; Zhu F; Dong X; Li B
Cancer Cell Int; 2020; 20():292. PubMed ID: 32655324
[TBL] [Abstract][Full Text] [Related]
3. C-phycocyanin suppresses transforming growth factor-β1-induced epithelial mesenchymal transition in human epithelial cells.
Pattarayan D; Rajarajan D; Ayyanar S; Palanichamy R; Subbiah R
Pharmacol Rep; 2017 Jun; 69(3):426-431. PubMed ID: 28288400
[TBL] [Abstract][Full Text] [Related]
4. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer.
Chen HY; Chiang YF; Huang JS; Huang TC; Shih YH; Wang KL; Ali M; Hong YH; Shieh TM; Hsia SM
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799801
[TBL] [Abstract][Full Text] [Related]
7. Fluorene-9-bisphenol inhibits epithelial-mesenchymal transition of human endometrial cancer Ishikawa cells by repressing TGF-β signaling pathway.
Wang L; Zhuang T; Li F; Wei W
Environ Sci Pollut Res Int; 2019 Sep; 26(26):27407-27413. PubMed ID: 31327139
[TBL] [Abstract][Full Text] [Related]
8. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
9. Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κ B/Snail signaling pathway in human gastric adenocarcinoma.
Zhu Y; Liu Y; Qian Y; Dai X; Yang L; Chen J; Guo S; Hisamitsu T
BMC Complement Altern Med; 2014 Nov; 14():433. PubMed ID: 25370696
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
11. Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGFβ pathway.
Bokhari AA; Lee LR; Raboteau D; Hamilton CA; Maxwell GL; Rodriguez GC; Syed V
Cancer Prev Res (Phila); 2014 Oct; 7(10):1045-55. PubMed ID: 25070663
[TBL] [Abstract][Full Text] [Related]
12. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.
Tian X; Fei Q; Du M; Zhu H; Ye J; Qian L; Lu Z; Zhang W; Wang Y; Peng F; Chen J; Liu B; Li Q; He X; Yin L
Cancer Med; 2019 Mar; 8(3):1197-1208. PubMed ID: 30741461
[TBL] [Abstract][Full Text] [Related]
13. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion.
Cheng HP; Huang CJ; Tsai ML; Ong HT; Cheong SK; Choo KB; Chiou SH
Int J Med Sci; 2021; 18(8):1798-1809. PubMed ID: 33746597
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin Promotes Invasion, Migration and Epithelial-Mesenchymal Transition of Human Endometrial Carcinoma Cell HEC-1A Through AKT and ERK1/2 Signaling.
Li Y; Xie Y; Cui D; Ma Y; Sui L; Zhu C; Kong H; Kong Y
Cell Physiol Biochem; 2015; 37(4):1503-12. PubMed ID: 26509489
[TBL] [Abstract][Full Text] [Related]
16. A FXYD5/TGF‑β/SMAD positive feedback loop drives epithelial‑to‑mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
Bai Y; Li LD; Li J; Chen RF; Yu HL; Sun HF; Wang JY; Lu X
Int J Oncol; 2020 Jan; 56(1):301-314. PubMed ID: 31746425
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
[TBL] [Abstract][Full Text] [Related]
18. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract][Full Text] [Related]
19. miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1.
Chen S; Luo Y; Cui L; Yang Q
Cell Cycle; 2020 Jul; 19(14):1740-1753. PubMed ID: 32635855
[TBL] [Abstract][Full Text] [Related]
20. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer.
Zong L; Chen K; Jiang Z; Chen X; Sun L; Ma J; Zhou C; Xu Q; Duan W; Han L; Lei J; Li X; Ma Q; Wang Z
J Exp Clin Cancer Res; 2017 Dec; 36(1):181. PubMed ID: 29228980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
